Mila Makovec, the first person in the world treated with a medicine tailored for her, battled Batten disease with a unique drug called milasen. Her mother's relentless efforts led to fundraising millions for the treatment. Despite initial success, Mila sadly passed away at age ten, highlighting the challenges of personalized medicine for rare diseases. The podcast dives into the future of genomic medicine, discussing innovative projects in the UK and the potential for accessible genetic treatments worldwide.